SCHEMBL30799900

CC(C)[C@@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)C1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)[C@H](C)O)C(=O)N[C@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](CCCNC(=N)N)C(=O)O

nearest known ligand 0.68

Predicted protein targets (top 13)

	gene	UniProt	supporting neighbours	confidence
▸	IL23R	Q5VWK5	7/20	0.68

▸	C5AR1	P21730	1/20	0.64

▸	CXCR4	P61073	5/20	0.62

▸	NPY1R	P25929	1/20	0.59

▸	NPY2R	P49146	1/20	0.59

▸	NPY4R	P50391	1/20	0.59

▸	NPY5R	Q15761	1/20	0.59

▸	MC4R	P32245	2/20	0.57

▸	MC5R	P33032	2/20	0.57

▸	MC3R	P41968	2/20	0.57

▸	MC1R	Q01726	2/20	0.57

▸	GLP1R	P43220	3/20	0.56

▸	GCGR	P47871	3/20	0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31182564	0.89	NPY1R (0.70)	IL23RCXCR4NPY1RNPY2RNPY4R
SCHEMBL30974492	0.89	CXCR4 (0.65)	IL23RC5AR1CXCR4NPY1RNPY2R
SCHEMBL31182704	0.89	NPY2R (0.67)	IL23RC5AR1CXCR4NPY1RNPY2R
SCHEMBL29903312	0.88	IL23R (0.67)	IL23RC5AR1CXCR4NPY1RNPY2R
SCHEMBL30607294	0.88	CXCR4 (0.72)	IL23RC5AR1CXCR4NPY1RNPY2R
SCHEMBL31457379	0.88	NPY2R (0.69)	IL23RC5AR1CXCR4NPY1RNPY2R
SCHEMBL31182666	0.88	CXCR4 (0.68)	IL23RCXCR4NPY1RNPY2RNPY4R
SCHEMBL31307240	0.88	CXCR4 (0.68)	C5AR1CXCR4NPY1RNPY2RNPY4R
SCHEMBL30527897	0.88	NPY1R (0.68)	IL23RC5AR1CXCR4NPY1RNPY2R
SCHEMBL30974222	0.88	CXCR4 (0.65)	IL23RC5AR1CXCR4NPY1RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-3427734-B1	COMPOSITIONS COMPRISING AN ANTI-ANGIOGENIC AGENT FOR USE IN AMELIORATING SYMPTOMS OF ALZHEIMER'S DISEASE	ALTERNATIVE EXTRACTS INC (CA)	2024-07-10	—	—	EP	disclosed
US-11925678-B2	Methods for diagnosing and treating Alzheimer's disease	Cava Healthcare Inc. (CA)	2024-03-12	—	—	US	disclosed